Clinical Trial Drug Tracker
Recently updated drug and biologic studies from ClinicalTrials.gov, with phase and status changes observed between daily snapshots.
- Recently updated studies: 1,000, as of Nov 12, 2026
- Daily change tracking since: Nov 10, 2026
Phase and status changes compare the same NCT record across daily snapshots. A new study is not a proven phase transition. A registry update may only reflect an administrative edit. Combined phases appear in both phase counts; a phase change is not necessarily an advancement. ClinicalTrials.gov · Updated Nov 12, 2026
About this data
A window into the pipeline. Not a verdict on a drug.
Source & coverage
The 1,000 most recently updated interventional studies with a drug or biological intervention in ClinicalTrials.gov. One row is one registered study, not one unique drug. Combination therapies, placebos and trials of already approved drugs can appear. Filters apply to this recent-study window, not the entire registry.
What counts as a change?
Phase and status changes compare the same NCT record across daily snapshots. A new study is not a proven phase transition. A registry update may only reflect an administrative edit. Combined phases appear in both phase counts; a phase change is not necessarily an advancement.
Timing & interpretation
Dates are the registry's posting dates, not the dates a clinical event occurred. The daily comparison retains up to 10,000 recently seen studies and 90 days of observed changes; changes between observations or outside that window may be missed. Sponsor-reported phase and recruitment status do not establish efficacy, trial success or regulatory approval.
For one modality over the whole registry, see radioligand therapy trials by phase, sponsor and country.